tm
Seeing Is Believing
tm
Seeing Is Believing
MBRX is currently covered by 1 analysts with an average price target of $22. This is a potential upside of $-15.21 (3628.81%) from yesterday's end of day stock price of $0.59.
Moleculin Biotech's activity chart (see below) currently has 9 price targets and 14 ratings on display. The stock rating distribution of MBRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 226 days.
Highest price target for MBRX is $22, Lowest price target is $22, average price target is $22.
Most recent stock forecast was given by from HC WAINWRIGHT on 24-Mar-2026. First documented stock forecast 17-Oct-2019.
Currently out of the existing stock ratings of MBRX, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$22
$18.73 (572.78%)
$4
Buy Since 09-Jun-2025
$4
$0.73 (22.32%)
$4
Buy Since 14-Dec-2023
$8
Hold Since 25-Mar-2025
$4
$0.73 (22.32%)
Buy Since 14-Apr-2021
$30
$26.73 (817.43%)
What is MBRX (Moleculin Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on MBRX (Moleculin Biotech) with a proven track record?
Which analyst has the most public recommendations on MBRX (Moleculin Biotech)?
Which analyst is the currently most bullish on MBRX (Moleculin Biotech)?
Which analyst is the currently most reserved on MBRX (Moleculin Biotech)?
